Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Atypical compaction behaviour of disordered lactose explained by a shift in type of compact fracture pattern.

Pazesh S, Persson AS, Alderborn G.

Int J Pharm X. 2019 Nov 8;1:100037. doi: 10.1016/j.ijpx.2019.100037. eCollection 2019 Dec.

2.

Amorphous solid dispersion formation via solvent granulation - A case study with ritonavir and lopinavir.

Trasi NS, Bhujbal S, Zhou QT, Taylor LS.

Int J Pharm X. 2019 Nov 12;1:100035. doi: 10.1016/j.ijpx.2019.100035. eCollection 2019 Dec.

3.

Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles.

Lê MQ, Carpentier R, Lantier I, Ducournau C, Fasquelle F, Dimier-Poisson I, Betbeder D.

Int J Pharm X. 2018 Dec 10;1:100001. doi: 10.1016/j.ijpx.2018.100001. eCollection 2019 Dec.

4.

Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids.

Li J, Cheng Y, Chen X, Zheng S.

Int J Pharm X. 2018 Dec 24;1:100002. doi: 10.1016/j.ijpx.2018.100002. eCollection 2019 Dec. Review.

5.

Real time calorimetric characterisation of clay - drug complex dispersions and particles.

Totea AM, Dorin I, Gavrilov G, Laity PR, Conway BR, Waters L, Asare-Addo K.

Int J Pharm X. 2018 Dec 21;1:100003. doi: 10.1016/j.ijpx.2018.100003. eCollection 2019 Dec.

6.

Glassy state molecular mobility and its relationship to the physico-mechanical properties of plasticized hydroxypropyl methylcellulose (HPMC) films.

Owusu-Ware SK, Boateng JS, Chowdhry BZ, Antonijevic MD.

Int J Pharm X. 2019 Aug 23;1:100033. doi: 10.1016/j.ijpx.2019.100033. eCollection 2019 Dec.

7.

Size-induced segregation during die filling.

Zakhvatayeva A, Hare C, Wu CY.

Int J Pharm X. 2019 Aug 19;1:100032. doi: 10.1016/j.ijpx.2019.100032. eCollection 2019 Dec.

8.

Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures.

Streck S, Neumann H, Nielsen HM, Rades T, McDowell A.

Int J Pharm X. 2019 Aug 13;1:100030. doi: 10.1016/j.ijpx.2019.100030. eCollection 2019 Dec.

9.

Combination of a rotating tube sample divider and dynamic image analysis for continuous on-line determination of granule size distribution.

Wilms A, Knop K, Kleinebudde P.

Int J Pharm X. 2019 Aug 12;1:100029. doi: 10.1016/j.ijpx.2019.100029. eCollection 2019 Dec.

10.

Industrial application of heat- and mass balance model for fluid-bed granulation for technology transfer and design space exploration.

Ochsenbein DR, Billups M, Hong B, Schäfer E, Marchut AJ, Lyngberg OK.

Int J Pharm X. 2019 Aug 12;1:100028. doi: 10.1016/j.ijpx.2019.100028. eCollection 2019 Dec.

11.

Mechanism investigation of ethosomes transdermal permeation.

Niu XQ, Zhang DP, Bian Q, Feng XF, Li H, Rao YF, Shen YM, Geng FN, Yuan AR, Ying XY, Gao JQ.

Int J Pharm X. 2019 Aug 7;1:100027. doi: 10.1016/j.ijpx.2019.100027. eCollection 2019 Dec.

12.

Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency.

Antonino RSCMQ, Ruggiero M, Song Z, Nascimento TL, Lima EM, Bohr A, Knopp MM, Löbmann K.

Int J Pharm X. 2019 Jul 22;1:100026. doi: 10.1016/j.ijpx.2019.100026. eCollection 2019 Dec.

13.

3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin.

Iliopoulos F, Sil BC, Moore DJ, Lucas RA, Lane ME.

Int J Pharm X. 2019 Jul 19;1:100025. doi: 10.1016/j.ijpx.2019.100025. eCollection 2019 Dec.

14.

Using zeta potential to study the ionisation behaviour of polymers employed in modified-release dosage forms and estimating their pKa.

Barbosa JAC, Abdelsadig MSE, Conway BR, Merchant HA.

Int J Pharm X. 2019 Jul 19;1:100024. doi: 10.1016/j.ijpx.2019.100024. eCollection 2019 Dec.

15.

Premium ethylcellulose polymer based architectures at work in drug delivery.

Adeleke OA.

Int J Pharm X. 2019 Jul 8;1:100023. doi: 10.1016/j.ijpx.2019.100023. eCollection 2019 Dec.

16.

Observation of high-temperature macromolecular confinement in lyophilised protein formulations using terahertz spectroscopy.

Shmool TA, Woodhams PJ, Leutzsch M, Stephens AD, Gaimann MU, Mantle MD, Kaminski Schierle GS, van der Walle CF, Zeitler JA.

Int J Pharm X. 2019 Jul 8;1:100022. doi: 10.1016/j.ijpx.2019.100022. eCollection 2019 Dec.

17.

A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro.

Duysburgh C, Van den Abbeele P, Krishnan K, Bayne TF, Marzorati M.

Int J Pharm X. 2019 Jul 6;1:100021. doi: 10.1016/j.ijpx.2019.100021. eCollection 2019 Dec.

18.

A head-to-head comparison of conjugation methods for VHHs: Random maleimide-thiol coupling versus controlled click chemistry.

van Moorsel MVA, Urbanus RT, Verhoef S, Koekman CA, Vink M, Vermonden T, Maas C, Pasterkamp G, Schiffelers RM.

Int J Pharm X. 2019 Jun 21;1:100020. doi: 10.1016/j.ijpx.2019.100020. eCollection 2019 Dec.

19.

Preclinical evaluation of topically-administered PEGylated Fab' lung toxicity.

Freches D, Rocks N, Patil HP, Perin F, Van Snick J, Vanbever R, Cataldo D.

Int J Pharm X. 2019 Jun 21;1:100019. doi: 10.1016/j.ijpx.2019.100019. eCollection 2019 Dec.

20.

Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler.

Dolovich MB, Kuttler A, Dimke TJ, Usmani OS.

Int J Pharm X. 2019 May 30;1:100018. doi: 10.1016/j.ijpx.2019.100018. eCollection 2019 Dec.

Supplemental Content

Loading ...
Support Center